{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:58:43Z","timestamp":1766087923613,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capnomed GmbH"},{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>\nWe tested the feasibility of ultrasound technology for generating pressurized intraperitoneal aerosol chemotherapy (usPIPAC) and compared its performance vs. comparator (PIPAC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>A piezoelectric ultrasound aerosolizer (NextGen, Sinaptec) was compared with the available technology (Capnopen, Capnomed). Granulometry was measured for water, Glc 5%, and silicone oil using laser diffraction spectrometry. Two- and three-dimensional (2D and 3D) spraying patterns were determined with methylene blue. Tissue penetration of doxorubicin (DOX) was measured by fluorescence microscopy in the enhanced inverted Bovine Urinary Bladder model (eIBUB). Tissue DOX concentration was measured by high-performance liquid chromatography (HPLC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The droplets median aerodynamic diameter was (usPIPAC vs. PIPAC): H<jats:sub>2<\/jats:sub>0: 40.4 (CI 10\u201390%: 19.0\u2013102.3) vs. 34.8 (22.8\u201352.7) \u00b5m; Glc 5%: 52.8 (22.2\u2013132.1) vs. 39.0 (23.7\u201365.2) \u00b5m; Silicone oil: 178.7 (55.7\u2013501.8) vs. 43.0 (20.2\u201378.5) \u00b5m. 2D and 3D blue ink distribution pattern of usPIPAC was largely equivalent with PIPAC, as was DOX tissue concentration (usPIPAC: 0.65 (CI 5-95%: 0.44\u20130.86) vs. PIPAC: 0.88 (0.59\u20131.17) ng\/ml, <jats:italic>p<\/jats:italic>\u2009=\u20090.29). DOX tissue penetration with usPIPAC was inferior to PIPAC: usPIPAC: 60.1 (CI 5.95%: 58.8\u201361.5) \u00b5m vs. PIPAC: 1172 (1157\u20131198) \u00b5m, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The homogeneity of spatial distribution (top, middle and bottom of the eIBUB) was comparable between modalities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>usPIPAC is feasible, but its performance as a drug delivery system remains currently inferior to PIPAC, in particular for lipophilic solutions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00464-022-09525-y","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T20:03:56Z","timestamp":1661803436000},"page":"7848-7858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Feasibility of pressurized intra peritoneal aerosol chemotherapy using an ultrasound aerosol generator (usPIPAC)"],"prefix":"10.1007","volume":"36","author":[{"given":"Phil","family":"H\u00f6ltzcke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iaroslav","family":"Sautkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Clere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Pott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5521-6237","authenticated-orcid":false,"given":"Marc A.","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"issue":"6","key":"9525_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/PPO.0000000000000235","volume":"22","author":"HS Kim","year":"2016","unstructured":"Kim HS, Chapiro J, Geschwind J-FH (2016) Interventional oncology: the fourth pillar of oncology. Cancer J (Sudbury, Mass) 22(6):363","journal-title":"Cancer J (Sudbury, Mass)"},{"issue":"4","key":"9525_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/17425247.2020.1736551","volume":"17","author":"W Ceelen","year":"2020","unstructured":"Ceelen W, Braet H, Van Ramshorst G, Willaert W, Remaut K (2020) Intraperitoneal chemotherapy for peritoneal metastases: an expert opinion. Expert Opin Drug Deliv 17(4):511\u2013522","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"9525_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1515\/pp-2017-0004","volume":"2","author":"M Steuperaert","year":"2017","unstructured":"Steuperaert M, Debbaut C, Segers P, Ceelen W (2017) Modelling drug transport during intraperitoneal chemotherapy. Pleura Perit 2(2):73\u201383","journal-title":"Pleura Perit"},{"issue":"2","key":"9525_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/pp-2017-0010","volume":"2","author":"E de Bree","year":"2017","unstructured":"de Bree E, Michelakis D, Stamatiou D, Romanos J, Zoras O (2017) Pharmacological principles of intraperitoneal and bidirectional chemotherapy. Pleura Perit 2(2):47\u201362","journal-title":"Pleura Perit"},{"key":"9525_CR5","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2019-0007","author":"ML Soucisse","year":"2019","unstructured":"Soucisse ML, Liauw W, Hicks G, Morris DL (2019) Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis. Pleura Perit. https:\/\/doi.org\/10.1515\/pp-2019-0007","journal-title":"Pleura Perit"},{"issue":"7","key":"9525_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","volume":"89","author":"RL Dedrick","year":"1997","unstructured":"Dedrick RL, Flessner MF (1997) Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst 89(7):480\u2013487","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"9525_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"W Solass","year":"2014","unstructured":"Solass W, Kerb R, M\u00fcrdter T, Giger-Pabst U, Strumberg D, Tempfer C et al (2014) Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 21(2):553\u2013559","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9525_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-07955-w","volume":"21","author":"M Mimouni","year":"2021","unstructured":"Mimouni M, Richard C, Adenot P, Letheule M, Tarrade A, Sandra O et al (2021) Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model. BMC Cancer 21(1):1\u201310","journal-title":"BMC Cancer"},{"issue":"4","key":"9525_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1067\/msy.2001.110224","volume":"129","author":"M Sch\u00e4fer","year":"2001","unstructured":"Sch\u00e4fer M, Kr\u00e4henb\u00fchl L (2001) Effect of laparoscopy on intra-abdominal blood flow. Surgery 129(4):385\u2013389","journal-title":"Surgery"},{"issue":"4","key":"9525_CR10","first-page":"378","volume":"184","author":"MK Schilling","year":"1997","unstructured":"Schilling MK, Redaelli C, Kr\u00e4henb\u00fchl L, Signer C, B\u00fcchler M (1997) Splanchnic microcirculatory changes during CO2 laparoscopy. J Am Coll Surg 184(4):378\u2013382","journal-title":"J Am Coll Surg"},{"key":"9525_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejso.2019.06.028","volume":"47","author":"M Alyami","year":"2019","unstructured":"Alyami M, Mercier F, Siebert M, Bonnot P-E, Laplace N, Villeneuve L et al (2019) Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 47:128\u2013133","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"9525_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cancers12010034","volume":"12","author":"G Nadiradze","year":"2020","unstructured":"Nadiradze G, Horvath P, Sautkin Y, Archid R, Weinreich F-J, K\u00f6nigsrainer A et al (2020) Overcoming drug resistance by taking advantage of physical principles: pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers 12(1):34","journal-title":"Cancers"},{"issue":"2","key":"9525_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/pp-2016-0011","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Sempoux C, Detlefsen S, Carr NJ, Bibeau F (2016) Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS). Pleura Perit 1(2):99\u2013107","journal-title":"Pleura Perit"},{"issue":"4","key":"9525_CR14","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","volume":"23","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Diaz-Carballo D, F\u00f6rster E, Zieren J, Giger-Pabst U (2016) Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol 23(4):1220\u20131224","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9525_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00464-017-5652-4","volume":"32","author":"A Bellendorf","year":"2018","unstructured":"Bellendorf A, Khosrawipour V, Khosrawipour T, Siebigteroth S, Cohnen J, Diaz-Carballo D et al (2018) Scintigraphic peritoneography reveals a non-uniform 99m Tc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model. Surg Endosc 32(1):166\u2013174","journal-title":"Surg Endosc"},{"issue":"1","key":"9525_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1080\/02656736.2019.1704891","volume":"37","author":"A Davigo","year":"2020","unstructured":"Davigo A, Passot G, Vassal O, Bost M, Tavernier C, Decullier E et al (2020) PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model. Int J Hyperth 37(1):144\u2013150","journal-title":"Int J Hyperth"},{"key":"9525_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.rmed.2019.05.016","volume":"153","author":"VC Galindo-Filho","year":"2019","unstructured":"Galindo-Filho VC, Alcoforado L, Rattes C, Paiva DN, Brand\u00e3o SCS, Fink JB et al (2019) A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: a randomized controlled trial with radiolabeled aerosols. Respir Med 153:60\u201367","journal-title":"Respir Med"},{"issue":"4","key":"9525_CR18","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"D G\u00f6hler","year":"2017","unstructured":"G\u00f6hler D, Khosrawipour V, Khosrawipour T, Diaz-Carballo D, Falkenstein TA, Zieren J et al (2017) Technical description of the microinjection pump (MIP\u00ae) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc 31(4):1778\u20131784","journal-title":"Surg Endosc"},{"key":"9525_CR19","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2018-0119","author":"M H\u00fcbner","year":"2018","unstructured":"H\u00fcbner M (2018) In search of evidence\u2013PIPAC on the fast lane. Pleura Perit. https:\/\/doi.org\/10.1515\/pp-2018-0119","journal-title":"Pleura Perit"},{"key":"9525_CR20","unstructured":"SinapTec. The ultrasound technology. https:\/\/www.sinaptec.fr\/en\/the-technology\/. Accessed 5 Sept 2021"},{"key":"9525_CR21","unstructured":"ARRIVE guidelines. https:\/\/arriveguidelines.org\/. Accessed 5 Sept 2021"},{"issue":"1","key":"9525_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/pp-2017-0006","volume":"2","author":"D Schnelle","year":"2017","unstructured":"Schnelle D, Weinreich F-J, Kibat J, Reymond MA (2017) A new ex vivo model for optimizing distribution of therapeutic aerosols: the (inverted) bovine urinary bladder. Pleura Perit 2(1):37\u201341","journal-title":"Pleura Perit"},{"key":"9525_CR23","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2019-0017","author":"I Sautkin","year":"2019","unstructured":"Sautkin I, Solass W, Weinreich F-J, K\u00f6nigsrainer A, Schenk M, Thiel K et al (2019) A real-time ex vivo model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models. Pleura Perit. https:\/\/doi.org\/10.1515\/pp-2019-0017","journal-title":"Pleura Perit"},{"key":"9525_CR24","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2020-0151","author":"ASI Castagna","year":"2021","unstructured":"Castagna ASI, Weinreich FJ, Lee HJ, K\u00f6nigsrainer A, Reymond MA, Nadiradze G (2021) Influence of pre-analytical sample preparation on drug concentration measurements in peritoneal tissue: an ex-vivo study. Pleura Perit. https:\/\/doi.org\/10.1515\/pp-2020-0151","journal-title":"Pleura Perit"},{"issue":"4","key":"9525_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1515\/pp-2016-0023","volume":"1","author":"W Solass","year":"2016","unstructured":"Solass W, Struller F, Horvath P, K\u00f6nigsrainer A, Sipos B, Weinreich F-J (2016) Morphology of the peritoneal cavity and pathophysiological consequences. Pleura Perit 1(4):193\u2013201","journal-title":"Pleura Perit"},{"issue":"4","key":"9525_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1007\/s00464-020-07546-z","volume":"35","author":"L Toussaint","year":"2021","unstructured":"Toussaint L, Sautkin Y, Illing B, Weinreich F-J, Nadiradze G, K\u00f6nigsrainer A et al (2021) Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Surg Endosc 35(4):1636\u20131643","journal-title":"Surg Endosc"},{"issue":"3","key":"9525_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.21037\/gs-2019-ursoc-11","volume":"10","author":"J Mun","year":"2021","unstructured":"Mun J, Park SJ, Kim HS (2021) Rotational intraperitoneal pressurized aerosol chemotherapy in a porcine model. Gland Surg 10(3):1271","journal-title":"Gland Surg"},{"key":"9525_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.10.015","author":"M Rahimi-Gorji","year":"2020","unstructured":"Rahimi-Gorji M, Van de Sande L, Debbaut C, Ghorbaniasl G, Braet H, Cosyns S et al (2020) Intraperitoneal aerosolized drug delivery: technology, recent developments, and future outlook. Adv Drug Deliv Rev. https:\/\/doi.org\/10.1016\/j.addr.2020.10.015","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"9525_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s004649900010","volume":"14","author":"MA Reymond","year":"2000","unstructured":"Reymond MA, Hu B, Garcia A, Reck T, K\u00f6ckerling F, Hess J et al (2000) Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc 14(1):51\u201355","journal-title":"Surg Endosc"},{"issue":"1\u20135","key":"9525_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0041-624X(97)00105-4","volume":"36","author":"JL Laborde","year":"1998","unstructured":"Laborde JL, Bouyer C, Caltagirone J-P, G\u00e9rard A (1998) Acoustic bubble cavitation at low frequencies. Ultrasonics 36(1\u20135):589\u2013594","journal-title":"Ultrasonics"},{"issue":"2","key":"9525_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1515\/pp-2016-0005","volume":"1","author":"M Reymond","year":"2016","unstructured":"Reymond M, Demtroeder C, Solass W, Winnekendonk G, Tempfer C (2016) Electrostatic precipitation pressurized intraperitoneal aerosol chemotherapy (ePIPAC): first in-human application. Pleura Perit 1(2):109\u2013116","journal-title":"Pleura Perit"},{"key":"9525_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-021-08567-y","author":"C Bachmann","year":"2021","unstructured":"Bachmann C, Sautkin I, Nadiradze G, Archid R, Weinreich F, K\u00f6nigsrainer A et al (2021) Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC). Surg Endosc. https:\/\/doi.org\/10.1007\/s00464-021-08567-y","journal-title":"Surg Endosc"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09525-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-022-09525-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-022-09525-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T13:17:09Z","timestamp":1663593429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-022-09525-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["9525"],"URL":"https:\/\/doi.org\/10.1007\/s00464-022-09525-y","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"type":"print","value":"0930-2794"},{"type":"electronic","value":"1432-2218"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"12 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marc Reymond has an equity interest in Capnomed GmbH, Zimmern o.R., Germany. Samuel Clere is an employee of Sinaptec, L\u00e9zennes, France. Phil H\u00f6ltzcke, Iaroslav Sautkin, Arianna Castagna, Alfred K\u00f6nigsrainer, and Peter Pott have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}